![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Midas Pharma Gmbh Ingelheim Am Rhein De, based in Germany, is a pharmaceutical company that stands out with its certifications from EDQM.
They are recognized for Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
One of their significant offerings is Clofazimine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2019-257 - Rev 01
This Chemical Type CEP, issued on January 27, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2054 associated with this CEP further emphasizes